Solid Biosciences Statistics Share Statistics Solid Biosciences has 77.87M
shares outstanding. The number of shares has increased by 100.84%
in one year.
Shares Outstanding 77.87M Shares Change (YoY) 100.84% Shares Change (QoQ) 0.03% Owned by Institutions (%) 99.99% Shares Floating 58.34M Failed to Deliver (FTD) Shares 17 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 9.85M, so 12.65% of the outstanding
shares have been sold short.
Short Interest 9.85M Short % of Shares Out 12.65% Short % of Float 15.03% Short Ratio (days to cover) 14.5
Valuation Ratios The PE ratio is -1.31 and the forward
PE ratio is -3.25.
Solid Biosciences's PEG ratio is
0.04.
PE Ratio -1.31 Forward PE -3.25 PS Ratio 0 Forward PS 125.3 PB Ratio 1.19 P/FCF Ratio -1.62 PEG Ratio 0.04
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Solid Biosciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 5.2,
with a Debt / Equity ratio of 0.18.
Current Ratio 5.2 Quick Ratio 5.2 Debt / Equity 0.18 Debt / EBITDA -0.2 Debt / FCF -0.24 Interest Coverage -381.55
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.25M Employee Count 100 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -18.57% in the
last 52 weeks. The beta is 2.55, so Solid Biosciences's
price volatility has been higher than the market average.
Beta 2.55 52-Week Price Change -18.57% 50-Day Moving Average 5.97 200-Day Moving Average 4.54 Relative Strength Index (RSI) 56.04 Average Volume (20 Days) 1,303,192
Income Statement
Revenue n/a Gross Profit -2.46M Operating Income -129.73M Net Income -124.7M EBITDA -121.9M EBIT -124.36M Earnings Per Share (EPS) -3.06
Full Income Statement Balance Sheet The company has 80.23M in cash and 24.18M in
debt, giving a net cash position of 56.06M.
Cash & Cash Equivalents 80.23M Total Debt 24.18M Net Cash 56.06M Retained Earnings -783.45M Total Assets 308.29M Working Capital 248.79M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -100.01M
and capital expenditures -654K, giving a free cash flow of -100.67M.
Operating Cash Flow -100.01M Capital Expenditures -654K Free Cash Flow -100.67M FCF Per Share -2.47
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields SLDB does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for SLDB is $15,
which is 153.4% higher than the current price. The consensus rating is "Buy".
Price Target $15 Price Target Difference 153.4% Analyst Consensus Buy Analyst Count 10
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Oct 28, 2022. It was a
backward
split with a ratio of 1:15.
Last Split Date Oct 28, 2022 Split Type backward Split Ratio 1:15
Scores Altman Z-Score 0.26 Piotroski F-Score 1
